Medtronic plans to spin off two of its businesses into a separate company, the latest move by the medtech giant to tighten its focus on the areas of high growth.
With $2.2 billion in revenue, the two businesses — patient monitoring and respiratory interventions — represent about 7% of Medtronic's $31.7 billion in annual sales in its latest fiscal year.
It's the second time this year Medtronic has announced plans to offload parts of its operations.
